<p><i>Innovation grants from the biotechnology creators of sustained acoustic medicine (sam®) will advance recipients’ careers in biomedical engineering and sports medicine.</i>&nbsp;</p>

Dr. Ralph Ortiz will present findings on the use of the (sam®) wearable ultrasound unit, which is proven to be effective for treating the challenging condition without invasive surgery or potentially addictive opioid-based medications.

The newest addition to the Fibrant product line

Clinical education director Dr. Rajiv Mallipudi will present on sam® research and treatment protocols in a program for members of The Orthobiologic Institute.

Attending PHATS since 2014, this year, ZetrOZ showcased sam® X1 and 2.0 to educate attendees on the benefits of sustained acoustic medicine for hockey professionals.

The Interventional Orthobiologics Foundation Conference is one of the largest gatherings of orthopedic and interventional pain specialists in the United States with a focus on innovation

New Fibrant Line Changes the Game of Fiber Grafting

Brazil orthopedic devices market is predicted to expand at a CAGR of more than 7% through 2027 owing to the rising disposable income, developing medical infrastructure, and increasing healthcare expenditure.

Isto Biologics, the Orthobiologics Pioneers, Named 2020 Top Orthopedic Solution Provider

Leader Biomedical has launched the OssGro® range of synthetic grafts to complement its existing eTiss® line of human allografts used for spine, trauma, and orthopaedic indications. The company will also enter the sports medicine market with the X-grip® anterior cruciate ligament (ACL) reconstruction system.